Research

Medical Sciences

Title :

A phase Iib openlabel randomized controlled trial to evaluate the efficacy & safety of Ivermectin in reducing viral loads in patients with hematological disorders who are admitted with Covid-19 infection (Ice study)

Area of research :

Medical Sciences

Focus area :

Science & Engineering Research Board - Covid-19 (SERB-COVID)

Principal Investigator :

Dr. B. George Head & Professor Christian Medical College Tamil Nadu

Timeline Start Year :

2020

Timeline End Year :

2021

Details

Total Budget (INR):

20,90,000

Organizations involved